Avrupa Birliği - Danca - EMA (European Medicines Agency)

astellas pharma europe bv - tacrolimus - graft afvisning - immunosuppressiva - profylakse af transplantationsafstødning hos voksne nyre- eller levertransplantationsmodtagere. behandling af allograft afvisning resistente over for behandling med andre immunosuppressive lægemidler hos voksne patienter.

Avrupa Birliği - Danca - EMA (European Medicines Agency)

norgine b.v. - ferrisk maltol - anæmi, jernmangel - antianemiske præparater - feraccru er indiceret hos voksne til behandling af jernmangel.

Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

norgine b.v. - misoprostol - tabletter - 25 mikrogram

Avrupa Birliği - Danca - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - svin - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - ethinylestradiol, levonorgestrel - filmovertrukne tabletter - 0,10+0,02 mg

Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

exeltis healthcare s.l - ethinylestradiol, levonorgestrel - filmovertrukne tabletter - 0,10+0,02 mg

Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

exeltis healthcare s.l - ethinylestradiol, levonorgestrel - filmovertrukne tabletter - 0,10+0,02 mg

Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

exeltis healthcare s.l - ethinylestradiol, levonorgestrel - filmovertrukne tabletter - 150+30 mikrogram

Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - ethinylestradiol, levonorgestrel - filmovertrukne tabletter - 0,10+0,02 mg

Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - ethinylestradiol, levonorgestrel - filmovertrukne tabletter - 0,10+0,02 mg